Rituximab Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 500mg, 100mg
Reference Brands:
Category:
Orphan Drugs
Injection consists of the active ingredient Rituximab. It is prescribed to treat lymph node disease, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Pemphigus Vulgaris and granulomatosis with polyangiitis. Non-Hodgkin's Lymphoma is a disease of the lymph tissue that affects the white blood cells. Chronic Lymphocytic Leukemia is the accumulation of abnormal lymphocytes, a type of white blood cells in the bone marrow and blood. Rheumatoid arthritis is a persistent inflammatory disease of the joints.
RITUXIMAB is available in Injection
and strengths such as 500mg, 100mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, RITUXIMAB is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
RITUXIMAB can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Granulomatosis with polyangiitis and microscopic polyangiitis are inflammatory disorders of the blood vessels that affect the lungs and kidneys. Pemphigus Vulgaris is an autoimmune disorder affecting the skin, the lining of the mouth, throat and genitals.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing